Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2×2 Randomized Controlled Trial

Conditions: Intracranial Arteriosclerosis; Cognitive Impairment

Interventions: Drug: Rosuvastatin; Drug: Ezetimibe; Drug: Recaticimab; Behavioral: Digital Cognitive Training; Behavioral: Active Control

Sponsors: Peking Union Medical College Hospital

Not yet recruiting